Go Pro

Elevance Health (ELV) Competitors

Elevance Health logo
$377.39 -1.92 (-0.51%)
Closing price 07/24/2026 03:59 PM Eastern
Extended Trading
$378.20 +0.81 (+0.21%)
As of 07/24/2026 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ELV vs. CNC, MOH, UNH, CI, and HUM

Should you buy Elevance Health stock or one of its competitors? MarketBeat compares Elevance Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Elevance Health include Centene (CNC), Molina Healthcare (MOH), UnitedHealth Group (UNH), Cigna Group (CI), and Humana (HUM). These companies are all part of the "managed health care" industry.

How does Elevance Health compare to Centene?

Elevance Health (NYSE:ELV) and Centene (NYSE:CNC) are both large-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, dividends, profitability, earnings, valuation and media sentiment.

Elevance Health currently has a consensus price target of $440.90, suggesting a potential upside of 16.83%. Centene has a consensus price target of $64.61, suggesting a potential upside of 1.99%. Given Elevance Health's stronger consensus rating and higher possible upside, equities analysts clearly believe Elevance Health is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
Centene
2 Sell rating(s)
11 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.25

Elevance Health has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market. Comparatively, Centene has a beta of 1.07, suggesting that its share price is 7% more volatile than the broader market.

In the previous week, Elevance Health had 12 more articles in the media than Centene. MarketBeat recorded 28 mentions for Elevance Health and 16 mentions for Centene. Centene's average media sentiment score of 1.37 beat Elevance Health's score of 1.20 indicating that Centene is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
23 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Centene
14 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has a net margin of 2.47% compared to Centene's net margin of -3.25%. Elevance Health's return on equity of 14.64% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
Centene -3.25%5.57%1.54%

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 0.4% of Centene shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Elevance Health has higher revenue and earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.41$5.66B$22.5016.77
Centene$194.78B0.16-$6.67B-$13.14N/A

Summary

Elevance Health beats Centene on 12 of the 16 factors compared between the two stocks.

How does Elevance Health compare to Molina Healthcare?

Molina Healthcare (NYSE:MOH) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

Molina Healthcare currently has a consensus target price of $203.38, indicating a potential upside of 2.90%. Elevance Health has a consensus target price of $440.90, indicating a potential upside of 16.83%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts plainly believe Elevance Health is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Molina Healthcare
2 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.18
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Elevance Health has higher revenue and earnings than Molina Healthcare. Molina Healthcare is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Molina Healthcare$45.43B0.23$472M-$0.18N/A
Elevance Health$199.13B0.41$5.66B$22.5016.77

Molina Healthcare has a beta of 0.74, indicating that its share price is 26% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

In the previous week, Molina Healthcare had 16 more articles in the media than Elevance Health. MarketBeat recorded 44 mentions for Molina Healthcare and 28 mentions for Elevance Health. Elevance Health's average media sentiment score of 1.20 beat Molina Healthcare's score of 0.64 indicating that Elevance Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Molina Healthcare
18 Very Positive mention(s)
4 Positive mention(s)
11 Neutral mention(s)
6 Negative mention(s)
1 Very Negative mention(s)
Positive
Elevance Health
23 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

98.5% of Molina Healthcare shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 1.4% of Molina Healthcare shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Elevance Health has a net margin of 2.47% compared to Molina Healthcare's net margin of -0.02%. Elevance Health's return on equity of 14.64% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Molina Healthcare-0.02% 3.73% 0.97%
Elevance Health 2.47%14.64%5.22%

Summary

Elevance Health beats Molina Healthcare on 12 of the 17 factors compared between the two stocks.

How does Elevance Health compare to UnitedHealth Group?

Elevance Health (NYSE:ELV) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

UnitedHealth Group has a net margin of 3.14% compared to Elevance Health's net margin of 2.47%. UnitedHealth Group's return on equity of 16.53% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Elevance Health2.47% 14.64% 5.22%
UnitedHealth Group 3.14%16.53%5.43%

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 0.2% of UnitedHealth Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Elevance Health presently has a consensus price target of $440.90, suggesting a potential upside of 16.83%. UnitedHealth Group has a consensus price target of $455.92, suggesting a potential upside of 8.45%. Given Elevance Health's higher possible upside, equities research analysts clearly believe Elevance Health is more favorable than UnitedHealth Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65
UnitedHealth Group
0 Sell rating(s)
5 Hold rating(s)
20 Buy rating(s)
2 Strong Buy rating(s)
2.89

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.8%. UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.2%. Elevance Health pays out 30.6% of its earnings in the form of a dividend. UnitedHealth Group pays out 59.7% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years and UnitedHealth Group has increased its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has higher revenue and earnings than Elevance Health. Elevance Health is trading at a lower price-to-earnings ratio than UnitedHealth Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Elevance Health$199.13B0.41$5.66B$22.5016.77
UnitedHealth Group$449.71B0.85$12.06B$15.5427.05

In the previous week, UnitedHealth Group had 54 more articles in the media than Elevance Health. MarketBeat recorded 82 mentions for UnitedHealth Group and 28 mentions for Elevance Health. UnitedHealth Group's average media sentiment score of 1.24 beat Elevance Health's score of 1.20 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Elevance Health
23 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
UnitedHealth Group
66 Very Positive mention(s)
6 Positive mention(s)
5 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.62, indicating that its share price is 38% less volatile than the broader market.

Summary

UnitedHealth Group beats Elevance Health on 14 of the 20 factors compared between the two stocks.

How does Elevance Health compare to Cigna Group?

Cigna Group (NYSE:CI) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment and analyst recommendations.

Cigna Group has higher revenue and earnings than Elevance Health. Cigna Group is trading at a lower price-to-earnings ratio than Elevance Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cigna Group$274.90B0.28$5.96B$23.5912.30
Elevance Health$199.13B0.41$5.66B$22.5016.77

Cigna Group has a beta of 0.29, suggesting that its share price is 71% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, suggesting that its share price is 33% less volatile than the broader market.

87.0% of Cigna Group shares are held by institutional investors. Comparatively, 89.2% of Elevance Health shares are held by institutional investors. 0.6% of Cigna Group shares are held by insiders. Comparatively, 0.3% of Elevance Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Elevance Health had 4 more articles in the media than Cigna Group. MarketBeat recorded 28 mentions for Elevance Health and 24 mentions for Cigna Group. Cigna Group's average media sentiment score of 1.35 beat Elevance Health's score of 1.20 indicating that Cigna Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cigna Group
17 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
23 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.8%. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years and Elevance Health has increased its dividend for 14 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and lower payout ratio.

Elevance Health has a net margin of 2.47% compared to Cigna Group's net margin of 2.26%. Cigna Group's return on equity of 19.75% beat Elevance Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cigna Group2.26% 19.75% 5.30%
Elevance Health 2.47%14.64%5.22%

Cigna Group currently has a consensus price target of $338.80, indicating a potential upside of 16.80%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 16.83%. Given Elevance Health's higher possible upside, analysts clearly believe Elevance Health is more favorable than Cigna Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cigna Group
0 Sell rating(s)
6 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.77
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

Summary

Cigna Group beats Elevance Health on 11 of the 19 factors compared between the two stocks.

How does Elevance Health compare to Humana?

Humana (NYSE:HUM) and Elevance Health (NYSE:ELV) are both large-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

Elevance Health has a net margin of 2.47% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 14.64% beat Humana's return on equity.

Company Net Margins Return on Equity Return on Assets
Humana0.82% 10.45% 3.75%
Elevance Health 2.47%14.64%5.22%

92.4% of Humana shares are owned by institutional investors. Comparatively, 89.2% of Elevance Health shares are owned by institutional investors. 0.2% of Humana shares are owned by insiders. Comparatively, 0.3% of Elevance Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Humana presently has a consensus price target of $327.17, indicating a potential downside of 15.80%. Elevance Health has a consensus price target of $440.90, indicating a potential upside of 16.83%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts clearly believe Elevance Health is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Humana
2 Sell rating(s)
15 Hold rating(s)
9 Buy rating(s)
2 Strong Buy rating(s)
2.39
Elevance Health
0 Sell rating(s)
8 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.65

In the previous week, Elevance Health had 14 more articles in the media than Humana. MarketBeat recorded 28 mentions for Elevance Health and 14 mentions for Humana. Humana's average media sentiment score of 1.42 beat Elevance Health's score of 1.20 indicating that Humana is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Humana
13 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elevance Health
23 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Humana$129.66B0.36$1.19B$9.3541.56
Elevance Health$199.13B0.41$5.66B$22.5016.77

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 0.9%. Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.8%. Humana pays out 37.9% of its earnings in the form of a dividend. Elevance Health pays out 30.6% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has increased its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Humana has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, Elevance Health has a beta of 0.67, suggesting that its stock price is 33% less volatile than the broader market.

Summary

Elevance Health beats Humana on 15 of the 20 factors compared between the two stocks.

Get Elevance Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELV and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELV vs. The Competition

MetricElevance HealthMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$81.91B$9.50B$7.06B$23.58B
Dividend Yield1.82%1.62%2.67%4.21%
P/E Ratio16.7725.7327.1430.98
Price / Sales0.4119.19582.3019.98
Price / Cash10.05141.0849.8132.09
Price / Book1.826.1110.284.73
Net Income$5.66B$179.69M$3.60B$1.07B
7 Day Performance1.26%-3.06%-1.27%-0.45%
1 Month Performance-4.42%-1.50%-1.67%-0.41%
1 Year Performance30.53%9.52%18.25%14.19%

Elevance Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELV
Elevance Health
4.8952 of 5 stars
$377.39
-0.5%
$440.90
+16.8%
+30.5%$81.91B$199.13B16.7797,100
CNC
Centene
4.0114 of 5 stars
$68.38
+1.5%
$63.22
-7.5%
+123.4%$33.77B$198.10BN/A61,100
MOH
Molina Healthcare
2.4374 of 5 stars
$243.34
+4.3%
$194.50
-20.1%
+19.8%$12.68B$45.08B71.9919,000
UNH
UnitedHealth Group
4.82 of 5 stars
$429.34
+1.1%
$421.04
-1.9%
+49.8%$389.90B$447.57B32.43390,000
CI
Cigna Group
4.8014 of 5 stars
$304.60
+3.8%
$338.80
+11.2%
-2.1%$80.57B$274.90B12.9167,700

Related Companies and Tools


This page (NYSE:ELV) was last updated on 7/26/2026 by MarketBeat.com Staff.
From Our Partners